ArticleJournal of gastrointestinal oncology2016
Malignant transformation of biliary adenofibroma: a rare biliary cystic tumor.
Article in Journal of gastrointestinal oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Imaging features of biliary adenofibroma of the liver with malignant transformation: a case report with literature review.BMC medical imaging · 2022Pooled it
- Benign Biliary Tumors and Precursor Neoplasms: An Updated Clinicopathological and Molecular Review Based on the 2026 WHO Classification.Biomedicines · 2026Review
- Review
- Coexistence of Small Duct Type and Biliary Adenofibroma-Associated Large Duct Type Intrahepatic Cholangiocarcinoma within a Single Lesion: A Case Report.Surgical case reports · 2026Article
- Imaging Findings of Biliary Adenofibroma of the Liver: A Case Report.Journal of the Korean Society of Radiology · 2025Article
- Biliary Adenofibroma and the Threat of Malignant Transformation.International journal of surgical pathology · 2025Review
- Imaging Features of Biliary Adenofibroma With Malignant Transformation: A Case Report and Literature Review.Cureus · 2024Article
- Intrahepatic Cholangiocarcinoma in a Background of Biliary Adenofibroma: A Rare Entity.Journal of gastrointestinal cancer · 2023Article
- Biliary adenofibroma: a precursor lesion of intrahepatic cholangiocarcinoma.Autopsy & case reports · 2023Article
- Malignant transformation of biliary adenofibroma combined with benign lymphadenopathy mimicking advanced liver carcinoma: A case report.World journal of clinical cases · 2022Article
- Imaging presentation of biliary adenofibroma: A case report.World journal of clinical cases · 2022Article
- Current and Emerging Molecular Markers of Liver Diseases: A Pathogenic Perspective.Gene expression · 2022Article
- Biliary Adenofibroma: A Rare Liver Tumor with Transition to Invasive Carcinoma.Case reports in surgery · 2022Article
- Benign biliary neoplasms and biliary tumor precursors.Pathologica · 2021Review
- Magnetic Resonance Imaging Findings of Biliary Adenofibroma.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2019Article
- A case of biliary adenofibroma of the liver with malignant transformation: a morphomolecular case report and review of the literature.Surgical case reports · 2019Article
- Hepatic Biliary Adenofibroma: Histological Characteristics, Diagnostic Challenges, and Its Role as a Precursor to Intrahepatic Cholangiocarcinoma.Journal of clinical and translational pathologyArticle
- Atypical Biliary Adenofibroma of the Liver: Related Treatment and Performance.Case reports in gastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biliary adenofibromas (BAFs) are rare, benign biliary cystic tumors with potential for malignant transformation. Of the eleven prior cases of BAF reported in the literature, six showed evidence of malignant transformation. We describe the clinical, imaging and pathology features of two cases of malignant BAF and review the existing literature to raise awareness of this entity and provide additional tools for diagnosing this rare tumor Additionally, we identified a loss of function mutation in the cyclin-dependent kinase inhibitor 2A (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.